Search results for " volume"

showing 10 items of 1162 documents

Determinants of bronchial hyperresponsiveness in subjects with rhinitis.

2005

Subjects with rhinitis but without asthma may have coexisting bronchial hyperresponsiveness, although the reasons for this are uncertain. To evaluate the factors that determine BHR in rhinitis we examined 410 patients with symptomatic rhinitis with forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) ≥ 80% of the predicted value. In all subjects a skin prick test (SPT) was performed, a determination of total serum IgE and an eosinophils count in the blood. Of the 410 subjects we found that 161 (39.3%) exhibited a methacholine PD20 of 800 mg or less (Group A), whereas 249 (60.7%) had a methacholine PD20 more of 800 mg (Group B). Despite the matched mean values for FEV…

AdultMaleVital capacitymedicine.medical_specialtyImmunologyVital CapacityGastroenterologyGroup B03 medical and health sciencesFEV1/FVC ratioLeukocyte Count0302 clinical medicineInternal medicineForced Expiratory VolumemedicineImmunology and AllergyHumansLife StyleBRONCHIAL HYPERRESPONSIVENESS; RHINITISAsthmaRhinitisSkin TestsPharmacologybusiness.industryRhinitis Allergic SeasonalPassive smokeImmunoglobulin Emedicine.diseaseRespiratory Function TestsEosinophilsBronchial hyperresponsivenessSpirometry030220 oncology & carcinogenesisBRONCHIAL HYPERRESPONSIVENESSMethacholineFemaleGeometric meanBronchial Hyperreactivitybusiness030215 immunologymedicine.drug
researchProduct

Replacement therapy for alpha-1-protease inhibitor deficiency in PiZ subjects with chronic obstructive lung disease

1988

In a six-month multicenter feasibility and safety study, 20 patients, who all had a congenital deficiency of alpha-1-protease inhibitor (A1PI) of the PiZ phenotype accompanied by a chronic obstructive lung disease, were treated with human-plasma-derived A1PI. A weekly dose of 60 mg/kg, administered intravenously, was shown to be sufficient to maintain patient serum levels above the threshold limit of 35 percent, the serum level of healthy persons of the MZ phenotype. This is supposed to be the minimal effective level for protection against the elastolytic attack of the lung and, therefore, satisfies one of the most important criteria of feasibility of long-term replacement therapy. The glob…

AdultMalealpha 1-Antitrypsin DeficiencymedicineHumansLung Diseases ObstructiveInfusions IntravenousAgedRadial immunodiffusionClinical Trials as TopicLungPancreatic Elastasebiologybusiness.industryBlood ProteinsGeneral MedicineMiddle AgedOuchterlony double immunodiffusionTrypsinmedicine.diseaseAlpha-1 Protease Inhibitor DeficiencyObstructive lung diseasePhenotypemedicine.anatomical_structureImmunologybiology.proteinFemaleAntibodyLung Volume MeasurementsbusinessNephelometrymedicine.drugThe American Journal of Medicine
researchProduct

Thyrotropin-releasing hormone has stimulatory effects on ventilation in humans

1991

Thyrotropin-releasing hormone (TRH) stimulates pituitary thyrotropin synthesis and release and also regulates autonomic nervous system functions by acting as a neuromodulator and neurotransmitter. In experimental animals a stimulation of ventilation by thyrotropin-releasing hormone was shown when applied at central nervous system sites that affect respiratory motor output. It was the goal of our study to investigate the respiratory properties of thyrotropin-releasing hormone on basal and stimulated (i.e. CO2-rebreathing) conditions following systemic thyrotropin-releasing hormone application in healthy humans. Thyrotropin-releasing hormone (200 micrograms, 400 micrograms intravenous) initia…

AdultMaleendocrine systemmedicine.medical_specialtyAdolescentRespiratory ratePhysiologyStatistics as TopicCentral nervous systemThyrotropin-releasing hormoneInternal medicinemedicineHumansRespiratory systemThyrotropin-Releasing Hormonebusiness.industryRespirationRespiratory Function TestsAutonomic nervous systemmedicine.anatomical_structureEndocrinologyBreathingFemalebusinessRespiratory minute volumeHormoneActa Physiologica Scandinavica
researchProduct

Effects of corticotropin-releasing hormone on respiratory parameters during sleep in normal men.

2009

Corticotropin-releasing hormone (CRH) is well-known to be a centrally acting respiratory stimulant after systemic application both in healthy subjects and in patients suffering from respiratory failure. In order to study the effects of CRH on sleep EEG and respiratory parameters during sleep, 14 healthy male volunteers were investigated in a single-blind placebo controlled design. After an adaptation night, polysomnography was performed during two successive nights between 23.00 hrs. and 7.00 hrs. During one night placebo was applied, on the other 50 μg ovine CRH was administered intravenously as a bolus every hour from 0.00 hrs. to 6.00 hrs. For the assessment of respiration, blood oxygen …

AdultMaleendocrine systemmedicine.medical_specialtyHydrocortisoneCorticotropin-Releasing HormoneEndocrinology Diabetes and MetabolismSleep REMPolysomnographyPlacebosCorticotropin-releasing hormoneEndocrinologyAdrenocorticotropic HormoneDouble-Blind MethodSleep and breathingInternal medicineInternal MedicinemedicineHumansRespiratory systemTidal volumeSlow-wave sleepmedicine.diagnostic_testbusiness.industryElectromyographyRespirationElectroencephalographyGeneral MedicineThoraxOxygenKineticsEndocrinologyRespiratory failureAnalepticAnesthesiabusinessSleephormones hormone substitutes and hormone antagonistsExperimental and clinical endocrinologydiabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
researchProduct

Quantitative analysis of emphysema in 3D using MDCT: Influence of different reconstruction algorithms

2008

Abstract Purpose The aim of the study was to compare the influence of different reconstruction algorithms on quantitative emphysema analysis in patients with severe emphysema. Material and methods Twenty-five patients suffering from severe emphysema were included in the study. All patients underwent inspiratory MDCT (Aquilion-16, slice thickness 1/0.8 mm). The raw data were reconstructed using six different algorithms: bone kernel with beam hardening correction (BHC), soft tissue kernel with BHC; standard soft tissue kernel, smooth soft tissue kernel (internal reference standard), standard lung kernel, and high-convolution kernel. The only difference between image data sets was the algorith…

AdultMalegenetic structuresinformation scienceAbsolute differenceStatistics NonparametricPulmonary function testingImaging Three-DimensionalHumansMedicinenatural sciencesRadiology Nuclear Medicine and imagingLung volumesAgedPhantoms Imagingbusiness.industryfood and beveragesSoft tissueReconstruction algorithmGeneral MedicineMiddle AgedRespiratory Function TestsPulmonary EmphysemaKernel (statistics)Radiographic Image Interpretation Computer-AssistedFemaleTomographyTomography X-Ray ComputedbusinessNuclear medicineAlgorithmQuantitative analysis (chemistry)AlgorithmsSoftwareEuropean Journal of Radiology
researchProduct

Influence of low temperature on bronchodilatation induced by terbutaline administered by metered dose or dry powder inhalers in asthmatics.

2000

Low temperatures may affect dose delivery efficacy and clinical effectiveness of medication aerosols. In this study we examine the effect of cold ambient temperature on the bronchodilatation produced by terbutaline delivered from a chlorofluorocarbon pressurized metered dose inhaler (pMDI) compared to a multi-dose dry powder inhaler (DPI). Fourteen stable asthmatics were studied on two consecutive days. On day 1, after measuring FEV1 at room temperature (22 degrees C), each patient was randomized to receive 500 microg of terbutaline delivered from pMDI or DPI stored for 24 h at 22 degrees C with FEV1 recorded 20 min post-dose; then, patients were placed in a chamber at -10 degrees C, and af…

AdultMalemedicine.drug_classTerbutalineCold storageBronchiBronchodilatorForced Expiratory VolumeAdministration InhalationmedicineTerbutalineHumansPharmacology (medical)PharmacologyDose-Response Relationship DrugCumulative doseChemistryInhalerAdrenergic beta-AgonistsMiddle AgedMetered-dose inhalerDry-powder inhalerAsthmaBronchodilator AgentsCold TemperatureBronchodilatationAnesthesiaFemalePowdersmedicine.drugFundamentalclinical pharmacology
researchProduct

Central obesity and hypertensionThe role of plasma endothelin

1996

Hypertension and central obesity are two conditions closely linked, but the mechanisms responsible for obesity-associated hypertension are still unclear. In the last few years, several studies addressed the role of endothelin-1 (ET-1) in the development and maintenance of hypertension. This study was designed to evaluate plasma ET-1 in normotensive and hypertensive central obese subjects compared with a lean healthy group. Our final goal was to analyze the relationship between plasma ET-1, blood pressure, and left ventricular structure and function in central obese subjects (both normotensives and hypertensives). ET-levels have been assessed by the radioimmunoassay method in 20 lean normote…

AdultMalemedicine.hormoneMean arterial pressuremedicine.medical_specialtyAmbulatory blood pressureMegalencephalic leukoencephalopathy with subcortical cystsRadioimmunoassayBody Mass IndexEndothelinsVentricular Dysfunction LeftHeart RateInternal medicineInternal MedicinemedicineHumansRadionuclide AngiographyEndothelin-1business.industryStroke VolumeStroke volumeBlood Pressure Monitoring Ambulatorymedicine.diseaseBody HeightObesity MorbidMean blood pressureBlood pressureEndocrinologyEchocardiographyHypertensionBody ConstitutionRegression AnalysisFemalebusinessBody mass indexAmerican Journal of Hypertension
researchProduct

Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbi…

2008

Summary Background The treatment of allergic asthma by specific immunotherapy (SIT) is hampered by potential side-effects. Objective The aim of this study was to study the effect of omalizumab, a monoclonal anti-IgE antibody, in combination with SIT in patients with seasonal allergic rhinoconjunctivitis (SAR) and co-morbid seasonal allergic asthma (SAA) incompletely controlled by conventional pharmacotherapy. Methods A randomized, double-blind, placebo-controlled, multi-centre trial was performed to assess the efficacy and safety of omalizumab (Xolair®) vs. placebo in combination with depigmented SIT (Depigoid®) during the grass pollen season. Omalizumab or placebo was started 2 weeks befor…

AdultMalemedicine.medical_specialtyAdolescentCombination therapyImmunologyOmalizumabOmalizumabAntibodies Monoclonal HumanizedPlacebolaw.inventionYoung AdultPharmacotherapyDouble-Blind MethodRandomized controlled triallawForced Expiratory VolumeInternal medicineAnti-Allergic AgentsmedicineClinical endpointHumansImmunology and AllergyChildConjunctivitis AllergicAsthmaPlant Extractsbusiness.industryAntibodies MonoclonalRhinitis Allergic SeasonalAntigens PlantMiddle Agedmedicine.diseaseCombined Modality TherapyAsthmaAntibodies Anti-IdiotypicRespiratory Function TestsTreatment OutcomeDesensitization ImmunologicAsthma Control QuestionnaireQuality of LifePhysical therapyPollenFemalebusinessmedicine.drugClinical & Experimental Allergy
researchProduct

Pulmonary emphysema in cystic fibrosis detected by densitometry on chest multidetector computed tomography.

2013

BackgroundHistopathological studies on lung specimens from patients with cystic fibrosis (CF) and recent results from a mouse model indicate that emphysema may contribute to CF lung disease. However, little is known about the relevance of emphysema in patients with CF. In the present study, we used computationally generated density masks based on multidetector computed tomography (MDCT) of the chest for non-invasive characterization and quantification of emphysema in CF.MethodsVolumetric MDCT scans were acquired in parallel to pulmonary function testing in 41 patients with CF (median age 20.1 years; range 7-66 years) and 21 non-CF controls (median age 30.4 years; range 4-68 years), and subj…

AdultMalemedicine.medical_specialtyAdolescentCystic FibrosisScienceCystic fibrosisPulmonary function testingHounsfield scaleMultidetector computed tomographyMedicineHumansLung volumesChildAgedEmphysemaMultidisciplinaryLungbusiness.industryQCase-control studyRMiddle Agedrespiratory systemmedicine.diseaserespiratory tract diseasesmedicine.anatomical_structureCase-Control StudiesMedicineFemaleRadiologybusinessDensitometryTomography X-Ray ComputedResearch ArticlePLoS ONE
researchProduct

Impact of Myocardial Fibrosis on Left Ventricular Function Evaluated by Feature-Tracking Myocardial Strain Cardiac Magnetic Resonance in Competitive …

2019

BACKGROUND To analyze the effect of myocardial fibrosis on left ventricular (LV) function evaluated by feature-tracking strain analysis by cine cardiac magnetic resonance (CMR) in competitive male triathletes with normal ejection fraction (EF).Methods and Results:78 asymptomatic male triathletes with >10 weekly training hours (43±11 years) and 28 male age-matched controls were studied by late gadolinium enhancement (LGE) and cine CMR. Global and segmental radial, longitudinal and circumferential strains were analyzed using feature-tracking cine CMR. Focal non-ischemic LGE was observed in 15 of 78 triathletes (19%, LGE+) with predominance in the basal inferolateral segments. LVEF was normal …

AdultMalemedicine.medical_specialtyAdolescentMagnetic Resonance Imaging Cine030204 cardiovascular system & hematologyAsymptomaticVentricular Function Left030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineFibrosisCardiac magnetic resonance imagingInternal medicineMedicineHumanscardiovascular diseasesAgedEjection fractionmedicine.diagnostic_testbusiness.industryMyocardiumStroke VolumeGeneral MedicineMiddle Agedmedicine.diseaseFibrosisAthletesembryonic structuresMyocardial straincardiovascular systemCardiologyMyocardial fibrosismedicine.symptomCardiology and Cardiovascular MedicinebusinessCardiac magnetic resonanceCardiomyopathiesRadial stressCirculation journal : official journal of the Japanese Circulation Society
researchProduct